QUOTED. 31 October 2019. Mike Mahoney.
Boston Scientific has reported sales of $2.7bn during Q3 2019, a year-on-year increase of 13.1%, exceeding analyst expectations. See what company CEO Mike Mahoney said about it here.
"We've seen great growth in Latin America, great growth in China and really nice growth in the ASEAN countries, as well as some parts of Europe." – Mike Mahoney, CEO, Boston Scientific Corp.
Click here for a free trial of Medtech Insight